Clopidogrel increases bleeding complications in patients undergoing heart rhythm device procedures

PACE - Pacing and Clinical Electrophysiology

Volumn 35, Issue 5, 2012, Pages 605-611

  Boulé, Stéphane ^a,b   Marquié, Christelle ^a   Vanesson Bricout, Claire ^c   Kouakam, Claude ^a   Brigadeau, François ^a   Guédon Moreau, Laurence ^a   Acheré, Charles ^a   Goéminne Boulé, Céline ^a   Lacroix, Dominique ^a,b   Klug, Didier ^a,b   Kacet, Salem ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

^c Schaffner Hospital   (France)

Author keywords

Antiplatelet; Clopidogrel; Complications; Hematoma; ICD; Pacemaker

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR EQUIPMENT; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY STENT; DEFIBRILLATOR; FEMALE; GENERATOR; HEART RHYTHM; HEART TAMPONADE; HEMATOMA; HEMATOTHORAX; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PERICARDIAL EFFUSION; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDY; SUBCLAVIAN VEIN; TRANSCATHETER AORTIC VALVE IMPLANTATION; VEIN PUNCTURE;

CARDIAC RESYNCHRONIZATION THERAPY; CASE-CONTROL STUDIES; COMORBIDITY; DRUG TOXICITY; FEMALE; FRANCE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84860835185     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2012.03354.x     Document Type: Article

References (11)

1. Rossini R, Capodanno D, Lettieri C, Musumeci G, Nijaradze T, Romano M, Lortkipanidze N, et al,. Prevalence, predictors, and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am J Cardiol 2011; 107: 186-194.
2. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS); European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al,. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501-2555.
3. Tompkins C, Henrikson CA,. Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation. Cardiol J 2011; 18: 103-109.
4. de Bono J, Nazir S, Ruparelia N, Bashir Y, Betts T, Rajappan K,. Perioperative management of anticoagulation during device implantation-the UK perspective. Pacing Clin Electrophysiol 2010; 33: 389-393.
5. Tompkins C, Cheng A, Dalal D, Brinker JA, Leng CT, Marine JE, Nazarian S, et al,. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55: 2376-2382.
6. Thal S, Moukabary T, Boyella R, Shanmugasundaram M, Pierce MK, Thai H, Goldman S,. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation. Pacing Clin Electrophysiol 2010; 33: 385-388.
7. Wiegand UK, LeJeune D, Boguschewski F, Bonnemeier H, Eberhardt F, Schunkert H, Bode F,. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: Influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004; 126: 1177-1186.
8. Dreger H, Grohmann A, Bondke H, Gast B, Baumann G, Melzer C,. Is antiarrhythmia device implantation safe under dual antiplatelet therapy? Pacing Clin Electrophysiol 2010; 33: 394-399.
9. Przybylski A, Derejko P, Kwasniewski W, Urbanczyk-Swic D, Zakrzewska J, Orszulak W, Orczykowski M, et al,. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry. Neth Heart J 2010; 18: 230-235.
10. Kutinsky IB, Jarandilla R, Jewett M, Haines DE,. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010; 3: 312-318.
11. Cano O, Osca J, Sancho-Tello MJ, Olague J, Castro JE, Salvador A,. Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices. Europace 2011; 13: 395-401.